Sector Alpha Week of 2026-09-11
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-11

NIBE Ltd

NIBE
Aerospace & Defence - Equipments

NIBE Ltd's price has outrun its earnings. +5.9% in a year against EPS −79.8% — the market is paying now for delivery later.

The sharpest disagreement: the price moved +5.9% in a year while annual EPS moved −79.8% — the difference is re-rating, and re-rating has to be repaid with earnings.

The price is in a confirmed uptrend (14 weeks in) while the P/E sits at the 83rd percentile of its own 10-year range. Underneath, the last four quarters read deteriorating — profit −1,300.0% year on year, and 25% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.

Stage
Deteriorating
partial read
Price
₹1,282
+5.9% 1Y
P/E
375.4×
83rd pctile
of its own 10-year range
Revenue (Jun 26)
₹63.0 Cr
−23.2% YoY
Profit (Jun 26)
₹−12.0 Cr
−1,300.0% YoY
Operating margin
−15.0%
−24.0 pp YoY
ROCE
5%
FY26
Cash conversion
25%
of profit, last 3 FY
Withheld from this page: Part of this page is deliberately not drawn: its two data sources disagree by up to 9.5% on reported income across 13 comparable periods, so nothing from the second source is placed here — the quarterly PEG curve, the quarterly return curves, the annual return-on-invested-capital overlay, the total-debt and debt-to-equity series and the F-score and the return-on-invested-capital reading are absent for that reason. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data. The quarterly history also begins where the primary source begins: 7 earlier quarters the second source carries are not spliced in front of it. Extending a reported profit series is stricter than showing a ratio chart — it needs a source that has been checked.
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

NIBE Ltd trades at ₹1,282, in a confirmed uptrend and 14 weeks into that stage. That is −3.5% against its own 200-day average. It sits at 44% of a 52-week range of ₹871 to ₹1,816. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (7 weeks and counting).

Today the stock is in a confirmed uptrend — week 14 of stage 2, confirmed. At ₹1,282 it trades −3.5% versus its 200-day average and sits at 44% of its 52-week range (₹871–₹1,816).

Sep 26: ₹1,282 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−3.5% versus the 200-day line, week 14 of stage 2
Price50-day avg200-day avg
S2S4S2S4S2₹2,279₹1,769₹1,259₹749₹239₹1,282₹1,329Sep 23Jun 24Mar 25Dec 25Sep 26
S2S4S2S4S2₹2,279₹1,769₹1,259₹749₹239₹1,282₹1,329Sep 23Mar 25Sep 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (417 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Sep 26

Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +15,612% while the NIFTY 500 moved +267% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (7 weeks and counting; last ahead the week of 2026-07-24) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

NIBE Ltd trades at 375.4× P/E, at the pricey end of its own range (83rd percentile). Its long-run median P/E is 133.1×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 375.4× is at the pricey end of its own range (83rd percentile), against a long-run median of 133.1× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 375.4× vs a 133.1× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 10.4-year window; loss-period spikes above 399× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
at the pricey end of its own range (83rd percentile)
P/EMedianEPS (TTM) (quarterly)
428.2×₹26.0323.4×₹19.5218.7×₹13.0114.0×₹6.59.2×₹0.0×375.40×₹4Mar 16Feb 24Nov 24Aug 25Aug 26
428.2×₹26.0323.4×₹19.5218.7×₹13.0114.0×₹6.59.2×₹0.0×375.40×₹4Mar 16Nov 24Aug 26
P/E
375.4×
83rd percentile of 10y

🚨 Why the multiple sits where it does: over the past year annual EPS moved −79.8% against a +5.9% price move — the price outran earnings, pushing the multiple UP its own range.

The price move, decomposed: over 3y, of the +36.8%/yr price move, ~+16.2%/yr came from earnings growth and ~+20.6 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources disagree by up to 9.5% on reported income across 13 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

03 · Stage: Deteriorating

Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

NIBE Ltd reads as deteriorating on its fundamental arc. Deteriorating — revenue, profit and EPS growth are shrinking (revenue growth −5.2% latest against +217.9% at its 12-quarter best), ROCE slipping at 5.0%. The read is built from 8 quarters across 4 curves, on partial evidence.

Growth, year by year: revenue −6.5% in FY26, profit −100.0% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn. Turnaround-year spikes shown pinned (▲).
Revenue YoYProfit YoYEPS YoY
653%348%460%174%267%0.0%73%−174%−120%−348%%%−6.5%−100%FY16FY21FY26
653%348%460%174%267%0.0%73%−174%−120%−348%%%−6.5%−100%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue rolling over
RevenueProfitEPS
239%337%164%202%89%67%14%−68%−61%−203%%%−5.2%−161.9%−136.3%Sep 23Dec 24Jun 26
239%337%164%202%89%67%14%−68%−61%−203%%%−5.2%−161.9%−136.3%Sep 23Dec 24Jun 26
ROCE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROCE
17%14%11%7.3%4.1%%5%FY23FY24FY26
17%14%11%7.3%4.1%%5%FY23FY24FY26
Revenue growth
Recovering
latest −5.2% · span −40.2% to +217.9%
Profit growth
Falling
latest −161.9% · span −165.5% to +520.0%
EPS growth
Falling
latest −136.3% · span −149.3% to +607.4%
ROCE
Falling
latest 5.0% · span 5.0%–16.0%

🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue−6.5%+65.3%+175.3%+48.6%
EPS−79.8%+41.2%+99.3%+47.0%
Share price+5.9%+36.8%+86.6%+65.5%
Revenue YoY (Jun 26)
−23.2%
latest quarter vs a year ago
Profit YoY (Jun 26)
−1,300.0%
latest quarter vs a year ago
Revenue 10y
48.6%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

24.1/100 — rank 23 of 25 in Aerospace & Defence - Equipments · 66% evidence confidence

NIBE Ltd scores 24.1 out of 100 against the 25 companies it is compared with in Aerospace & Defence - Equipments, ranking 23. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 3 + 5.4 + 10 + 5.7 = 24.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

NIBE Ltd reported ₹63.0 Cr of revenue in the Jun 26 quarter, −23.2% year on year. Over 10 years it has compounded at 48.6% a year. The last full year, FY26, came in at ₹474 Cr. The last four reported quarters add to ₹455 Cr.

FY26 revenue came in at ₹474 Cr (−6.5% on the year), capping 10 years at 48.6% compound. The latest quarter (Jun 26) printed ₹63.0 Cr, −23.2% year on year.

FY26 revenue ₹474 Cr (−6.5% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
48.6% a year over 10 years
RevenueYoY growth
548653%411460%274267%13773%0−120%₹ Cr%₹474−6.5%FY16FY21FY26
548653%411460%274267%13773%0−120%₹ Cr%₹474−6.5%FY16FY21FY26
Jun 26: ₹63.0 Cr (−23.2% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
281354%211243%140131%7020%0−91%₹ Cr%₹63−23.2%Sep 23Dec 24Jun 26
281354%211243%140131%7020%0−91%₹ Cr%₹63−23.2%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +0.1% growth against the decade's 48.6% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew −5.2% over the last 4 quarters against +11.5%/yr over the last 8 — rolling over.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

NIBE Ltd's operating margin is −15.0% in the Jun 26 quarter, −24.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −17.0% to 13.0%. The current quarter sits inside that band.

The latest quarter's operating margin is −15.0%, −24.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −17.0%–13.0%.

🚨 Why the margin moved: operating margin went −24.2 pp year on year while gross margin went −4.7 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY26: 9.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a −17.0–13.0% band over 13 years
operating marginYoY change (pp)
15%23%6.7%12%−2.0%2.0%−11%−8.4%−19%−19%%%9%−3%FY14FY20FY26
15%23%6.7%12%−2.0%2.0%−11%−8.4%−19%−19%%%9%−3%FY14FY20FY26
Jun 26: −15.0% operating margin (−24.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
23%7.3%12%−1.1%2.0%−9.5%−8.4%−18%−19%−26%%%−15%−24%Sep 23Dec 24Jun 26
23%7.3%12%−1.1%2.0%−9.5%−8.4%−18%−19%−26%%%−15%−24%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

NIBE Ltd posted a net loss of ₹12.0 Cr in the Jun 26 quarter. Full-year FY26 profit was ₹0.0 Cr. That loss is 19.0% of the quarter's revenue. The same quarter a year earlier earned ₹1.0 Cr. 3 of the last 12 reported quarters were loss-making.

Jun 26 profit was ₹−12.0 Cr, −1,300.0% year on year. On the full year, FY26 printed ₹0.0 Cr (−100.0%).

FY26 profit ₹0.0 Cr (−100.0% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
Net profitYoY growth
29926%22651%15375%7100%0−176%₹ Cr%₹0−100%FY16FY21FY26
29926%22651%15375%7100%0−176%₹ Cr%₹0−100%FY16FY21FY26
Jun 26: ₹−12.0 Cr (−1,300.0% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
32860%18280%5−300%−9−880%−23−1,460%₹ Cr%₹−12−1,300%Sep 23Dec 24Jun 26
32860%18280%5−300%−9−880%−23−1,460%₹ Cr%₹−12−1,300%Sep 23Dec 24Jun 26

🚨 Why profit moved: revenue contributed −23.2% and the margin −24.0 pp — the quarter was revenue-led despite a thinner margin.

Pace comparison, last four quarters: profit −587.5% vs revenue +0.1%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 25% of NIBE Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹−35.0 Cr of operating cash against ₹0.0 Cr of profit. After ₹124 Cr of capital spending, ₹−159 Cr was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.

FY26: operating cash of ₹−35.0 Cr against reported profit of ₹0.0 Cr, leaving free cash of ₹−159 Cr after ₹124 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 25% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹−35.0 Cr vs profit ₹0.0 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution. FY24/FY26 reflects an acquisition year — point shown clipped.
25% of 3-year profit arrived as cash
Operating cashNet profitFree cash
357−20−48−76₹ Cr₹−35₹0₹−22FY16FY21FY26
357−20−48−76₹ Cr₹−35₹0₹−22FY16FY21FY26
FY26: CFO = 93% of profit (three-year rate 25%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash.
Conversion100%
232%−247%−725%−1,204%−1,682%%93%FY16FY21FY26
232%−247%−725%−1,204%−1,682%%93%FY16FY21FY26

🚨 Why conversion sits at 25%: the cash cycle tightened 1,211 days between FY21 and FY26 — cash that used to wait in the cycle now reaches the bank sooner. Less than 70% of profit arriving as cash is the thing to watch on this page.

Router verdict: the bigger cash user is investment — capital spending ran 5.2× depreciation over three years, so the next section's job is to check what that build-out is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

NIBE Ltd's cash conversion cycle runs 92 days in FY26, down from 1,303 days in FY21. Capital spending ran ₹273 Cr over the last 3 years. At FY26 sales of ₹474 Cr each day of that cycle holds about ₹1.3 Cr, so roughly ₹119 Cr sits inside the business at any moment.

FY26: debtors at 178 days, inventory at 43 days — roughly 1.4 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 92 days, tighter than FY21's 1,303.

The full loop: cash goes out to suppliers and production on day 0; stock waits 43 days to sell; customers pay about 178 days after that; and suppliers themselves are paid at 129 days — netting out to the 92-day cycle.

In money terms: at FY26 sales of ₹474 Cr, each day of the cycle holds about ₹1.3 Cr — so the 92-day loop keeps roughly ₹119 Cr sitting inside the business at any moment.

FY26: a 92-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
−1,211 days vs FY21
Cash cycleInventory daysDebtor daysPayable days
1,8531,356858360−137days92d43d178d129dFY14FY17FY20FY23FY26
1,8531,356858360−137days92d43d178d129dFY14FY20FY26

On the investment side: capital spending of ₹273 Cr over the last 3 fiscal years against ₹53.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹62.0 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹124 Cr, work-in-progress ₹62.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
134986225−11₹ Cr₹124₹62FY16FY18FY21FY23FY26
134986225−11₹ Cr₹124₹62FY16FY21FY26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

NIBE Ltd earns a ROCE of 5% in FY26. That is up from a trough of 0% in FY19. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 0.0% net margin on 0.73× asset turns.

FY26 ROCE is 5%, recovered from a FY19 trough of 0% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY26): 0.0% net margin × 0.73× asset turns × 1.88× balance-sheet leverage ≈ 0.0% on equity. Margin does its share; leverage is a meaningful part of the equation.

FY26: ROCE 5% Return on capital employed by fiscal year, % (line). 13-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY19's 0%
ROCEWACC
17%13%8.0%3.4%−1.3%%5%FY14FY17FY20FY23FY26
17%13%8.0%3.4%−1.3%%5%FY14FY20FY26

The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 9.5% on reported income across 13 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.

NIBE Ltd carries ₹120 Cr of borrowings against ₹348 Cr of equity in FY26, a debt-to-equity of 0.34. Operating profit covers the interest bill 3×. Over 5 years borrowings went from ₹2.0 Cr to ₹120 Cr. Capital spending ran ₹273 Cr across the last 3 of those years.

FY26: borrowings of ₹120 Cr against equity of ₹348 Cr — a debt-to-equity of 0.34. Operating profit covers the interest bill 3×. Over 5 years borrowings went from ₹2.0 Cr to ₹120 Cr while capital spending ran ₹273 Cr in just the last 3 — part of the build-out is riding on borrowed money.

FY26: borrowings ₹120 Cr at 0.34× equity Borrowings by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 13-year window. Quarterly balance-sheet history is not held for India — annual is the honest resolution.
the debt trajectory
BorrowingsDebt-to-equity
1301.2×970.9×650.6×320.2×0−0.1×₹ Cr×₹1200.34×FY14FY17FY20FY23FY26
1301.2×970.9×650.6×320.2×0−0.1×₹ Cr×₹1200.34×FY14FY20FY26

The total-debt and debt-to-equity series, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 9.5% on reported income across 13 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Foreign institutions added 3.7 points of NIBE Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 11.5% of the company. Promoters moved −1.6 points over the same window, to 51.5%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: +3.7 points over 8 quarters to 11.5%; Promoters: −1.6 points over 8 quarters to 51.5%; Domestic institutions: +0.1 points over 8 quarters to 0.6%.

Why the register moved: foreign institutions drove it (+3.7 points), absorbed on the other side by promoters (−1.6 points) — steady accumulation by institutions reading the same numbers this page reads.

Fiscal-year ends: promoters +3.4 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
58%42%27%11%−3.9%%53.4%8.7%0.3%37.6%Mar 24Mar 25Mar 26
58%42%27%11%−3.9%%53.4%8.7%0.3%37.6%Mar 24Mar 25Mar 26
Foreign institutions added 3.7 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
60%44%28%12%−4.0%%51.5%11.5%0.6%36.5%Sep 23Mar 25Jul 26
60%44%28%12%−4.0%%51.5%11.5%0.6%36.5%Sep 23Mar 25Jul 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

NIBE Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Aerospace & Defence - Equipments
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Sigma Advanced System LtdSIGMAADV 77.9/100Favorable setup82% evidence LEADER 28.4/35 Revenue 100% · PAT 20.3% · OPM change 307 pp 95% evidence 17.2/25 ROCE 60.8% · OPM 16% 76% evidence 12.5/20 P/E 95.1× · PEG — 50% evidence 19.8/20 RS sector 113.1% · RS bench 161.3% · 1Y 481.8%12 of 12 weeks ahead 100% evidence
Exact sum: 28.4 + 17.2 + 12.5 + 19.8 = 77.9 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
2Paras Defence and Space Technologies LtdPARAS 70.7/100Favorable setup82% evidence LEADER 25.8/35 Revenue 36.6% · PAT 54.8% · OPM change 2 pp 95% evidence 17.1/25 ROCE 17.2% · OPM 25% 76% evidence 9.0/20 P/E 125× · PEG — 50% evidence 18.8/20 RS sector 29.1% · RS bench 66.5% · 1Y 117.2%12 of 12 weeks ahead 100% evidence
Exact sum: 25.8 + 17.1 + 9 + 18.8 = 70.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
3MTAR Technologies LtdMTARTECH 67.2/100Favorable setup90% evidence TURNING 30.4/35 Revenue 53.5% · PAT 100% · OPM change 6 pp 100% evidence 15.3/25 ROCE 15.1% · OPM 24% 100% evidence 8.0/20 P/E 165× · PEG — 50% evidence 13.5/20 RS sector 29.8% · RS bench 63% · 1Y 419.4%5 of 12 weeks ahead 100% evidence
Exact sum: 30.4 + 15.3 + 8 + 13.5 = 67.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Azad Engineering LtdAZAD 64.0/100Mixed-positive evidence93% evidence LEADER 24.2/35 Revenue 29% · PAT 41.4% · OPM change 1 pp 100% evidence 12.8/25 ROCE 11.9% · OPM 37% 100% evidence 8.2/20 P/E 132× · PEG 2.29 65% evidence 18.8/20 RS sector 15.1% · RS bench 50.7% · 1Y 80.6%10 of 12 weeks ahead 100% evidence
Exact sum: 24.2 + 12.8 + 8.2 + 18.8 = 64 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Rossell Techsys LtdROSSTECH 62.9/100Mixed-positive evidence83% evidence BREAKING OUT 28.8/35 Revenue 82.9% · PAT 68.8% · OPM change 1.8 pp 100% evidence 8.0/25 ROCE 11.5% · OPM 14.4% 100% evidence 8.9/20 P/E 173× · PEG — 15% evidence 17.2/20 RS sector 13.1% · RS bench 48.2% · 1Y 69.8%8 of 12 weeks ahead 100% evidence
Exact sum: 28.8 + 8 + 8.9 + 17.2 = 62.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Sika Interplant Systems LtdSIKA 62.4/100Mixed-positive evidence94% evidence BREAKING OUT 19.1/35 Revenue 0.5% · PAT 9.8% · OPM change 1.1 pp 100% evidence 21.9/25 ROCE 34.6% · OPM 19.5% 100% evidence 13.0/20 P/E 66.4× · PEG 1.01 100% evidence 8.4/20 RS sector -10.2% · RS bench 7.8% · 1Y -4.3%8 of 9 weeks ahead 70% evidence
Exact sum: 19.1 + 21.9 + 13 + 8.4 = 62.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Vinyas Innovative Technologies LtdVINYAS 60.0/100Thin evidence · provisional57% evidence BREAKING OUT 21.7/35 Revenue 65% · PAT 100% · OPM change 3 pp 48% evidence 19.0/25 ROCE 21.4% · OPM 13% 95% evidence 10.8/20 P/E 63.1× · PEG — 15% evidence 8.5/20 RS sector -17.6% · RS bench 31.3% · 1Y 24.9%11 of 11 weeks ahead 70% evidence
Exact sum: 21.7 + 19 + 10.8 + 8.5 = 60 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
8Data Patterns (India) LtdDATAPATTNS 58.3/100Mixed-positive evidence100% evidence LEADER 22.8/35 Revenue 33.9% · PAT 24.2% · OPM change -5 pp 100% evidence 19.8/25 ROCE 21.9% · OPM 27% 100% evidence 3.0/20 P/E 100× · PEG 3.94 100% evidence 12.7/20 RS sector 7.7% · RS bench 40.5% · 1Y 95%10 of 12 weeks ahead 100% evidence
Exact sum: 22.8 + 19.8 + 3 + 12.7 = 58.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
9Jaykay Enterprises LtdJAYKAY 54.3/100Mixed-positive evidence74% evidence ASLEEP 29.0/35 Revenue 100% · PAT 100% · OPM change 1.8 pp 95% evidence 8.1/25 ROCE 8.2% · OPM 14.2% 95% evidence 11.1/20 P/E 61.2× · PEG — 15% evidence 6.1/20 RS sector -20.9% · RS bench 1.6% · 1Y 13.3%1 of 10 weeks ahead 70% evidence
Exact sum: 29 + 8.1 + 11.1 + 6.1 = 54.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -20.9% and the one-year return is 13.3%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
10Astra Microwave Products LtdASTRAMICRO 53.5/100Mixed-positive evidence100% evidence LEADER 16.0/35 Revenue 3.9% · PAT 17.4% · OPM change -1 pp 100% evidence 17.7/25 ROCE 20.3% · OPM 19% 100% evidence 4.8/20 P/E 84.4× · PEG 3.3 100% evidence 15.0/20 RS sector 7.8% · RS bench 39.8% · 1Y 66.6%12 of 12 weeks ahead 100% evidence
Exact sum: 16 + 17.7 + 4.8 + 15 = 53.5 · Decision use: Price leads the evidence: RS versus the benchmark is 39.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
11Hindustan Aeronautics LtdHAL 52.3/100Mixed-positive evidence100% evidence BREAKING OUT 13.9/35 Revenue 7.4% · PAT 12.2% · OPM change 1 pp 100% evidence 20.4/25 ROCE 32% · OPM 28% 100% evidence 8.2/20 P/E 35.2× · PEG 3.54 100% evidence 9.8/20 RS sector -17.1% · RS bench 11.6% · 1Y 11.4%8 of 12 weeks ahead 100% evidence
Exact sum: 13.9 + 20.4 + 8.2 + 9.8 = 52.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Apollo Micro Systems LtdAPOLLO 51.8/100Mixed-positive evidence100% evidence FADING 19.6/35 Revenue 68.8% · PAT 74.2% · OPM change -10 pp 100% evidence 13.4/25 ROCE 14.5% · OPM 21% 100% evidence 7.2/20 P/E 129× · PEG 1.6 100% evidence 11.6/20 RS sector 6.4% · RS bench 38.8% · 1Y 38.6%8 of 12 weeks ahead 100% evidence
Exact sum: 19.6 + 13.4 + 7.2 + 11.6 = 51.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Dynamatic Technologies LtdDYNAMATECH 48.5/100Mixed-negative evidence83% evidence TURNING 18.3/35 Revenue 17.3% · PAT 0% · OPM change 3 pp 100% evidence 9.3/25 ROCE 10.2% · OPM 13% 100% evidence 9.2/20 P/E 140× · PEG — 15% evidence 11.7/20 RS sector -6.1% · RS bench 25% · 1Y 82.9%3 of 12 weeks ahead 100% evidence
Exact sum: 18.3 + 9.3 + 9.2 + 11.7 = 48.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Mishra Dhatu Nigam LtdMIDHANI 45.5/100Mixed-negative evidence100% evidence TURNING 16.6/35 Revenue 18.2% · PAT 13.4% · OPM change -5 pp 100% evidence 11.5/25 ROCE 11.3% · OPM 15% 100% evidence 7.5/20 P/E 62.1× · PEG 5.62 100% evidence 9.9/20 RS sector -9.5% · RS bench 20.5% · 1Y 18.7%4 of 12 weeks ahead 100% evidence
Exact sum: 16.6 + 11.5 + 7.5 + 9.9 = 45.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Bharat Electronics LtdBEL 45.0/100Mixed-negative evidence100% evidence TURNING 14.7/35 Revenue 19.8% · PAT 11.8% · OPM change -3 pp 100% evidence 19.3/25 ROCE 36.4% · OPM 25% 100% evidence 7.5/20 P/E 48.1× · PEG 3.54 100% evidence 3.5/20 RS sector -27.8% · RS bench -2.2% · 1Y 9%0 of 12 weeks ahead 100% evidence
Exact sum: 14.7 + 19.3 + 7.5 + 3.5 = 45 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Ideaforge Technology LtdIDEAFORGE 44.5/100Mixed-negative evidence74% evidence ASLEEP 26.7/35 Revenue 100% · PAT 100% · OPM change 152.7 pp 74% evidence 1.3/25 ROCE -2.8% · OPM 3.4% 100% evidence 8.5/20 P/E 928× · PEG — 15% evidence 8.0/20 RS sector -3.5% · RS bench 24.1% · 1Y 44.1%7 of 12 weeks ahead 100% evidence
Exact sum: 26.7 + 1.3 + 8.5 + 8 = 44.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17High Energy Batteries (India) Ltd504176 43.3/100Mixed-negative evidence67% evidence TURNING 6.7/35 Revenue 1.5% · PAT -3.5% · OPM change -32.1 pp 95% evidence 14.2/25 ROCE 20.4% · OPM -26.5% 76% evidence 12.3/20 P/E 38.9× · PEG — 50% evidence 10.1/20 RS sector — · RS bench 4.7% · 1Y —4 of 4 weeks ahead 25% evidence
Exact sum: 6.7 + 14.2 + 12.3 + 10.1 = 43.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Zen Technologies LtdZENTEC 41.4/100Mixed-negative evidence69% evidence FADING 5.1/35 Revenue -23.4% · PAT -27.8% · OPM change -14 pp 95% evidence 16.7/25 ROCE 16.2% · OPM 27% 76% evidence 10.2/20 P/E 85.6× · PEG — 15% evidence 9.4/20 RS sector -6.6% · RS bench 13.1% · 1Y 16.5%5 of 10 weeks ahead 70% evidence
Exact sum: 5.1 + 16.7 + 10.2 + 9.4 = 41.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19BEML LtdBEML 40.5/100Mixed-negative evidence91% evidence BREAKING OUT 15.9/35 Revenue 12.8% · PAT -40.1% · OPM change 8.2 pp 74% evidence 3.5/25 ROCE 7.7% · OPM 0.2% 100% evidence 10.7/20 P/E 94.4× · PEG 1.18 100% evidence 10.4/20 RS sector -17% · RS bench 12% · 1Y -0.9%6 of 12 weeks ahead 100% evidence
Exact sum: 15.9 + 3.5 + 10.7 + 10.4 = 40.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Bharat Dynamics LtdBDL 35.2/100Mixed-negative evidence93% evidence TURNING 12.1/35 Revenue -18.7% · PAT -7.1% · OPM change 33 pp 100% evidence 13.3/25 ROCE 13.8% · OPM 15% 100% evidence 5.9/20 P/E 83.8× · PEG 4.44 65% evidence 3.9/20 RS sector -35.7% · RS bench -12.4% · 1Y -17.6%2 of 12 weeks ahead 100% evidence
Exact sum: 12.1 + 13.3 + 5.9 + 3.9 = 35.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21AXISCADES Technologies LtdAXISCADES 33.1/100Adverse evidence93% evidence ASLEEP 11.9/35 Revenue 3.5% · PAT -55% · OPM change -2.3 pp 100% evidence 3.9/25 ROCE 3.6% · OPM 4.7% 100% evidence 10.9/20 P/E 238× · PEG 1.39 65% evidence 6.4/20 RS sector -12% · RS bench 17% · 1Y 27.5%0 of 12 weeks ahead 100% evidence
Exact sum: 11.9 + 3.9 + 10.9 + 6.4 = 33.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Avantel LtdAVANTEL 32.1/100Adverse evidence83% evidence ASLEEP 9.9/35 Revenue -3.2% · PAT -67.2% · OPM change 4.6 pp 100% evidence 10.2/25 ROCE 9.6% · OPM 24.8% 100% evidence 8.6/20 P/E 242× · PEG — 15% evidence 3.4/20 RS sector -26.5% · RS bench -1.1% · 1Y -11.6%4 of 12 weeks ahead 100% evidence
Exact sum: 9.9 + 10.2 + 8.6 + 3.4 = 32.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23NIBE Ltdthis pageNIBE 24.1/100Adverse evidence66% evidence FADING 3.0/35 Revenue -5.2% · PAT -80% · OPM change -24 pp 95% evidence 5.4/25 ROCE 4.8% · OPM -15% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 5.7/20 RS sector -29.8% · RS bench 4.7% · 1Y 7.1%7 of 11 weeks ahead 70% evidence
Exact sum: 3 + 5.4 + 10 + 5.7 = 24.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24DCX Systems LtdDCXINDIA 24.0/100Adverse evidence71% evidence BASING 5.9/35 Revenue -46.5% · PAT -80% · OPM change -10.9 pp 95% evidence 4.2/25 ROCE 0.9% · OPM -10.4% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 3.9/20 RS sector -27.1% · RS bench -12.3% · 1Y -37.9%1 of 10 weeks ahead 70% evidence
Exact sum: 5.9 + 4.2 + 10 + 3.9 = 24 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25Aequs LtdAEQUS 39.1/100Thin evidence · provisional35% evidence BREAKING OUT 14.9/35 Revenue — · PAT — · OPM change -7.3 pp 45% evidence 4.2/25 ROCE 1.7% · OPM 3.7% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —12 of 12 weeks ahead 0% evidence
Exact sum: 14.9 + 4.2 + 10 + 10 = 39.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is NIBE Ltd's share price today?

NIBE Ltd trades at ₹1,282, +5.9% over the past year. The company is valued at ₹1,988 Cr. The stock sits at 44% of its 52-week range of ₹871–₹1,816, −3.5% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 14 weeks in. — as of 11 September 2026.

What were NIBE Ltd's latest quarterly results?

NIBE Ltd reported revenue of ₹63.0 Cr and a net loss of ₹12.0 Cr for the Jun 26 quarter. Revenue fell 23.2% and profit fell 1,300.0% year on year. Earnings per share were ₹−7.23. The operating margin was −15.0%, 24.0 pp lower than a year earlier. — as of 11 September 2026.

What is NIBE Ltd's revenue?

NIBE Ltd reported revenue of ₹63.0 Cr in the Jun 26 quarter, −23.2% year on year. For the full FY26 fiscal year, revenue was ₹474 Cr (−6.5%). Over the last 10 years revenue compounded at 48.6% a year. — as of 11 September 2026.

What is NIBE Ltd's profit?

NIBE Ltd earned ₹−12.0 Cr of net profit in the Jun 26 quarter, −1,300.0% year on year. Full-year FY26 profit was ₹0.0 Cr. The operating margin ran −15.0% in the latest quarter. — as of 11 September 2026.

What is NIBE Ltd's market cap?

NIBE Ltd's market capitalisation is ₹1,988 Cr at a share price of ₹1,282. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.

What is NIBE Ltd's P/E ratio?

NIBE Ltd trades at a P/E of 375.4×, at the 83rd percentile of its own 10-year range, against a long-run median of 133.1×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.

Does NIBE Ltd pay a dividend?

Yes — NIBE Ltd's dividend payout was 34% of profit in FY26, and it recorded a payout in 4 of its last 12 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.

Is NIBE Ltd overvalued?

On its own history, NIBE Ltd looks expensive: its P/E of 375.4× sits at the 83rd percentile of its 10-year range (long-run median 133.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.

Is NIBE Ltd growing?

Not right now — NIBE Ltd's latest numbers are shrinking: latest-quarter revenue −23.2% year on year, profit −1,300.0%, and the margin −24.0 pp at −15.0%. The earnings engine currently reads: deteriorating — as of 11 September 2026.

How is NIBE Ltd performing?

NIBE Ltd is in a confirmed uptrend, 14 weeks in. Its latest quarter's revenue fell 23.2% and profit fell 1,300.0% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 11 September 2026.

What stage is NIBE Ltd in?

Deteriorating — revenue, profit and EPS growth are shrinking (revenue growth −5.2% latest against +217.9% at its 12-quarter best), ROCE slipping at 5.0%. The read comes from the last 12 quarters of growth (revenue growth −5.2% latest, profit growth −161.9% latest, eps growth −136.3% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.

Is NIBE Ltd in an uptrend?

Yes — the price is in a confirmed uptrend (week 14 of stage 2), trading −3.5% versus its 200-day average and at 44% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.

Is NIBE Ltd beating the market?

Not lately — on a trailing-13-week view NIBE Ltd is currently behind the NIFTY 500 (7 weeks and counting; last ahead the week of 2026-07-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +15,612% against the NIFTY 500's +267% — ahead of the index over the full window. — as of 11 September 2026.

Will NIBE Ltd's share price go up?

This page publishes no price forecast for NIBE Ltd. What it measures instead: the share price is ₹1,282, the price is in a confirmed uptrend 14 weeks in. Its P/E of 375.4× sits at the 83rd percentile of its own 10-year range. — as of 11 September 2026.

Who owns NIBE Ltd?

Promoters hold 51.5% of NIBE Ltd, foreign institutions 11.5%, domestic institutions 0.6% and the public 36.5% (latest quarter). The biggest move on the register over the last two years: Foreign institutions added 3.7 points over 8 quarters. — as of 11 September 2026.

Does NIBE Ltd have too much debt?

It is moderate — NIBE Ltd's debt-to-equity is 0.34, and operating profit covers the interest bill 3×. FY26 borrowings were ₹120 Cr against equity of ₹348 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.

What is NIBE Ltd's capex?

NIBE Ltd spent ₹273 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹124 Cr, with ₹62.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.

What is NIBE Ltd's cash flow?

NIBE Ltd consumed ₹35.0 Cr of operating cash in FY26 — cash flowed out rather than in (free cash flow: ₹−159 Cr). Reported profit that year was ₹0.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 11 September 2026.

Is NIBE Ltd's profit real cash?

Not fully — over the last 3 fiscal years, 25% of NIBE Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹−35.0 Cr against reported profit of ₹0.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.

Where is NIBE Ltd in its business cycle?

NIBE Ltd's FY26 operating margin was 9.0%, against a 13-year band of −17.0%–13.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran −15.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.

What could break the NIBE Ltd story?

The sharpest disagreement: the price moved +5.9% in a year while annual EPS moved −79.8% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.

Is NIBE Ltd a stock worth studying right now?

This is not investment advice. The machine read: NIBE Ltd's price has outrun its earnings. +5.9% in a year against EPS −79.8% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-11. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI